SMMT icon

Summit Therapeutics
SMMT

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $4.76M invested in Summit Therapeutics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$49.4K
2
+$47K
3
+$4K
4
UBS Group
UBS Group
Switzerland
+$2K

Top Sellers

1
-$80K
2
-$29.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.86M
2
$537K
3
$408K
4
$388K
5
$310K
6
$201K
7
$47K
8
$4K
9
$2K
10
$1K
11
$1K
12
$1K